SCHEMBL903072

SCHEMBL903072

O=C(I)C1(C(=O)Nc2ccc(F)cc2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 10/20 0.47
ALDH1A1 P00352 2/20 0.47
GAA P10253 1/20 0.46
HDAC1 Q13547 1/20 0.46
KDR P35968 4/20 0.46
AXL P30530 3/20 0.46
RET P07949 2/20 0.46
KIT P10721 2/20 0.46
FLT3 P36888 2/20 0.46
PDGFRA P16234 1/20 0.46
EGFR P00533 2/20 0.45
TGM2 P21980 1/20 0.43
AURKA O14965 1/20 0.43
RIPK2 O43353 1/20 0.43
ABCB11 O95342 1/20 0.43
ABL1 P00519 1/20 0.43
ERBB2 P04626 1/20 0.43
NTRK1 P04629 1/20 0.43
LCK P06239 1/20 0.43
PGR P06401 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12468984 0.89 ALDH1A1 (0.53) METALDH1A1GAAHDAC1KDR
SCHEMBL13906173 0.85 MET (0.48) METALDH1A1GAAHDAC1KDR
SCHEMBL13927461 0.85 MET (0.48) METALDH1A1GAAHDAC1KDR
SCHEMBL105644 0.84 ALDH1A1 (0.48) METALDH1A1GAAHDAC1KDR
SCHEMBL2286282 0.84 ALDH1A1 (0.48) METALDH1A1GAAHDAC1KDR
SCHEMBL29693549 0.83 MET (0.54) METKDRAXLRETKIT
SCHEMBL4401200 0.83 MET (0.54) METKDRAXLRETKIT
SCHEMBL23982911 0.83 ALDH1A1 (0.47) METALDH1A1GAAHDAC1KDR
SCHEMBL13271309 0.83 ALDH1A1 (0.50) METALDH1A1GAAHDAC1KDR
SCHEMBL4398555 0.83 GAA (0.53) METALDH1A1GAAHDAC1KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012044572-A1 DUAL INHIBITORS OF MET AND VEGF FOR THE TREATMENT OF CASTRATION- RESISTANT PROSTATE CANCER AND OSTEOBLASTIC BONE METASTASES EXELIXIS, INC. (US) 2012-04-05 WO disclosed